文献速递生殖医学

子宫腺肌症对接受供卵移植女性体外受精结局的影响:一项前瞻性观察性研究

Impact of adenomyosis on in vitro fertilization outcomes in women undergoing donor oocyte transfers: a prospective observational study.
PubMed 文献 · Fertil Steril · 2023-12-01

这项前瞻性观察性队列研究纳入接受首次供卵单胚胎移植的不孕患者,比较有子宫腺肌症(n=114)与无子宫腺肌症(n=114)者的生殖结局。子宫腺肌症未显著影响种植率、临床妊娠率或活产率,但流产率显著更高(35.4% vs. 18.1%);联合带(JZ)直接征象、弥漫性JZ腺肌症及重度腺肌症与流产风险升高相关。

要点

  • 子宫腺肌症未显著影响供卵单胚胎移植的种植率、临床妊娠率和活产率。
  • 子宫腺肌症组流产率显著高于无子宫腺肌症组(35.4% vs. 18.1%)。
  • JZ直接征象、弥漫性JZ腺肌症和重度腺肌症与流产风险升高相关。

核心结论

  • 子宫腺肌症未显著降低供卵移植患者的种植几率,但JZ直接征象和疾病严重程度是流产的显著危险因素。
  • 研究强调在评估和管理不孕患者时,进行彻底超声检查和详细的子宫腺肌症分类的重要性。

研究设计与样本

  • 前瞻性观察性队列研究,在大学附属体外受精中心进行。
  • 纳入2019年1月至2023年1月期间接受首次供卵移植的不孕患者,有子宫腺肌症者114例,无子宫腺肌症者114例。
  • 子宫腺肌症经2维或3维经阴道超声发现至少一项直接征象确认,并按类型(弥漫性或局灶性)、位置(内肌层或外肌层和/或联合带[JZ])及子宫受累程度(轻度、中度或重度)分类。
  • 患者经人工或自然子宫内膜准备周期后,行囊胚期单胚胎移植。

主要发现

  • 子宫腺肌症的存在未显著影响种植率、临床妊娠率或活产率。
  • 有子宫腺肌症的女性流产率显著高于无子宫腺肌症者(35.4% vs. 18.1%)。
  • 经阴道超声检测到JZ子宫腺肌症与流产相对风险升高超过三倍相关(RR 3.28;95%CI 1.38-7.78)。
  • 仅在外肌层检测到子宫腺肌症特征与更高的持续妊娠率相关(RR 0.30;95%CI 0.13-0.72)。
  • 弥漫性JZ子宫腺肌症和重度子宫腺肌症分别使流产相对风险增加两倍(RR 2.29;95%CI 1.22-4.30 和 RR 2.20;95%CI 1.19-4.04)。

临床怎么用

  • 作者强调在评估和管理不孕患者时,进行彻底超声检查和详细的子宫腺肌症分类的重要性。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To prospectively examine the association between adenomyosis type, location, and severity with reproductive outcomes in patients undergoing single embryo transfer (SET) with embryos derived from donor oocytes. DESIGN: A prospective observational cohort study. SETTING: University-affiliated in vitro fertilization center. PATIENTS: Patients with infertility with (n = 114) and without (n = 114) adenomyosis who received their first donor oocyte transfer between January 2019 and January 2023 were included in this study. INTERVENTIONS: Adenomyosis was confirmed with the presence of at least one direct feature visualized by 2- or 3-dimensional transvaginal ultrasound and classified according to type (diffuse or focal), localization (inner or outer myometrium and/or junctional zone [JZ]), and uterine extension (mild, moderate, or severe). After an artificial or natural endometrial preparation cycle, patients underwent SET in the blastocyst stage. MAIN OUTCOME MEASURES: The primary outcome was the implantation rate. The secondary outcomes were the clinical pregnancy, live birth, and miscarriage rates after SET. RESULTS: The presence of adenomyosis did not significantly affect the implantation, clinical pregnancy, or live birth rates. However, women with adenomyosis had a significantly higher miscarriage rate than those without adenomyosis (35.4% vs. 18.1%, respectively). The multivariate analysis assessed possible risk factors for each clinical outcome considered in the study and showed that adenomyosis affected the risk of miscarriage. Specifically, transvaginal sonography detection of adenomyosis in the JZ was associated with over threefold higher relative risk of miscarriage (relative risk [RR], 3.28; 95% confidence interval [CI], 1.38-7.78). Conversely, adenomyosis features detected exclusively in the outer myometrium were associated with a higher ongoing pregnancy rate (RR, 0.30; 95% CI, 0.13-0.72). Diffuse adenomyosis in the JZ and severe adenomyosis increased the relative risk of miscarriage two-fold (RR, 2.29; 95% CI, 1.22-4.30 and RR, 2.20; 95% CI, 1.19-4.04, respectively). CONCLUSIONS: This study demonstrated that although adenomyosis did not significantly reduce the odds of implantation, the direct signs of adenomyosis in the JZ and disease severity are significant risk factors for miscarriage in patients receiving donor oocyte transfers. This study highlights the importance of thorough ultrasound examination and detailed adenomyosis classification in the assessment and management of patients with infertility.

来源:Fertil Steril,查看原文。版权归原作者所有。

引用

  1. Cozzolino M, Cosentino M, Loiudice L, et al. Impact of adenomyosis on in vitro fertilization outcomes in women undergoing donor oocyte transfers: a prospective observational study. Fertil Steril. 2023. PMID: 38043844. doi:10.1016/j.fertnstert.2023.11.034

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。